281 related articles for article (PubMed ID: 26291451)
1. Systematic Review and Meta-Analysis: Circulating miRNAs for Diagnosis of Hepatocellular Carcinoma.
Huang JT; Liu SM; Ma H; Yang Y; Zhang X; Sun H; Zhang X; Xu J; Wang J
J Cell Physiol; 2016 Feb; 231(2):328-35. PubMed ID: 26291451
[TBL] [Abstract][Full Text] [Related]
2. Identification of circulating MicroRNAs as novel potential biomarkers for hepatocellular carcinoma detection: a systematic review and meta-analysis.
Li G; Shen Q; Li C; Li D; Chen J; He M
Clin Transl Oncol; 2015 Sep; 17(9):684-93. PubMed ID: 25956842
[TBL] [Abstract][Full Text] [Related]
3. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
[TBL] [Abstract][Full Text] [Related]
4. Circulating microRNAs as biomarkers in hepatocellular carcinoma screening: a validation set from China.
Jiang L; Cheng Q; Zhang BH; Zhang MZ
Medicine (Baltimore); 2015 Mar; 94(10):e603. PubMed ID: 25761179
[TBL] [Abstract][Full Text] [Related]
5. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
[TBL] [Abstract][Full Text] [Related]
6. Plasma miR-15b-5p, miR-338-5p, and miR-764 as Biomarkers for Hepatocellular Carcinoma.
Chen Y; Chen J; Liu Y; Li S; Huang P
Med Sci Monit; 2015 Jun; 21():1864-71. PubMed ID: 26119771
[TBL] [Abstract][Full Text] [Related]
7. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yu F; Lu Z; Chen B; Dong P; Zheng J
Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
[TBL] [Abstract][Full Text] [Related]
8. Potential Role of Circulating microRNA-21 for Hepatocellular Carcinoma Diagnosis: A Meta-Analysis.
Liao Q; Han P; Huang Y; Wu Z; Chen Q; Li S; Ye J; Wu X
PLoS One; 2015; 10(6):e0130677. PubMed ID: 26114756
[TBL] [Abstract][Full Text] [Related]
9. Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma.
Zhuang C; Jiang W; Huang D; Xu L; Yang Q; Zheng L; Wang X; Hu L
Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):386-96. PubMed ID: 26669589
[TBL] [Abstract][Full Text] [Related]
10. Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma.
An Y; Gao S; Zhao WC; Qiu BA; Xia NX; Zhang PJ; Fan ZP
World J Gastroenterol; 2018 Jun; 24(24):2596-2604. PubMed ID: 29962816
[TBL] [Abstract][Full Text] [Related]
11. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S
Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996
[TBL] [Abstract][Full Text] [Related]
12. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
Zuo D; Chen L; Liu X; Wang X; Xi Q; Luo Y; Zhang N; Guo H
Tumour Biol; 2016 May; 37(5):6539-49. PubMed ID: 26637228
[TBL] [Abstract][Full Text] [Related]
13. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage.
Lin L; Lu B; Yu J; Liu W; Zhou A
Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):397-404. PubMed ID: 26724963
[TBL] [Abstract][Full Text] [Related]
14. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
Yang L; Xu Q; Xie H; Gu G; Jiang J
Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
[TBL] [Abstract][Full Text] [Related]
15. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
Chen L; Chu F; Cao Y; Shao J; Wang F
Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function.
Okajima W; Komatsu S; Ichikawa D; Miyamae M; Kawaguchi T; Hirajima S; Ohashi T; Imamura T; Kiuchi J; Arita T; Konishi H; Shiozaki A; Moriumura R; Ikoma H; Okamoto K; Taniguchi H; Itoh Y; Otsuji E
Oncotarget; 2016 Aug; 7(33):53820-53836. PubMed ID: 27462777
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs as a novel class of diagnostic biomarkers in detection of hepatocellular carcinoma: a meta-analysis.
Yin H; Peng X; Ren P; Cheng B; Li S; Qin C
Tumour Biol; 2014 Dec; 35(12):12317-26. PubMed ID: 25204672
[TBL] [Abstract][Full Text] [Related]
18. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma.
Li J; Jin B; Wang T; Li W; Wang Z; Zhang H; Song Y; Li N
Cancer Biomark; 2019; 26(4):501-512. PubMed ID: 31658041
[TBL] [Abstract][Full Text] [Related]
19. The predictive powers of plasma trefoil factor 3 or its related micro RNAs for patients with hepatocellular carcinoma.
Zhang C; Xia R; Zhang B; Wang H
BMC Cancer; 2018 Nov; 18(1):1110. PubMed ID: 30424721
[TBL] [Abstract][Full Text] [Related]
20. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]